CVS Caremark, Express Scripts and OptumRx dramatically mark up specialty generic drugs to affiliated pharmacies, the Federal ...
Units of CVS Health Corp., Cigna Group and UnitedHealth Group Inc. charged significantly more than the national average ...
FTC report reveals significant markups by top PBMs on specialty drugs, driving $7.3 billion in revenue and raising costs for ...
Pharmacy benefit managers, which serve as the middlemen between drug makers, insurers and pharmacies, reaped $7.3 billion in ...
Agency commissioners voted unanimously on Tuesday to publish the report, which makes similar allegations against the ...
On Tuesday, the Federal Trade Commission released its second interim staff report on prescription drug middlemen. The report ...
Major pharmacy-benefit managers generated $7.3 billion in markups on specialty drugs from pharmacies they are affiliated with ...
The U.S. Federal Trade Commission on Tuesday published the second part of its investigation into how prescription drug ...
The Federal Trade Commission suggests that PBMs profit from specialty generic drugs such as those for cancer and HIV and ...
UnitedHealth’s net income plummeted to its lowest level since 2019 amid hefty costs, including some from the Change ...
Oncology treatment increasingly involves combinations of novel oral and biologic drugs. While combo approaches aren’t new, there are significant cost implications of combining high priced ...
A long-awaited report from the US Federal Trade Commission (FTC) on pharmacy benefit managers ... PBMs now account for nearly 70% of all specialty drug revenue, according to the report.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback